Investigation of antimutagenic potential of Embelia Ribes fruit extract against genotoxicity and oxidative stress induced by Cyclophosphamide

Pharmacologyonline

Volumn 3, Issue , 2010, Pages 867-885

  Tripathi, Pankaj ^a   Tripathi, Rina ^b   Patel, R K ^a  

^a GANPAT UNIVERSITY   (India)

^b Shri Sarvajanik Pharmacy College   (India)

Author keywords

Antioxidant enzymes; Chromosomal aberration; Cyclophosphamide; Embelia ribes; Micronucleus; Sperm abnormality assay

Indexed keywords

ANTIMUTAGENIC AGENT; CYCLOPHOSPHAMIDE; EMBELIA RIBES EXTRACT; GLUTATHIONE; MALONALDEHYDE; METHANOL; PLANT EXTRACT; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG MECHANISM; DRUG SCREENING; EMBELIA; EMBELIA RIBES; ENZYME ACTIVITY; FRUIT; GENOTOXICITY; GERM LINE; MALE; MICRONUCLEUS; MOUSE; NONHUMAN; OXIDATIVE STRESS; SEMEN ABNORMALITY; SPECTROPHOTOMETRY;

EID: 79551547734     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. Brookes P. The early history of the biological alkylating agents. Mutation Res.1990; 233: 3-14.
2. Fraiser LH, Kanekal S, Kehrer JP. Cyclophosphamide Toxicity. Drugs 1991; 42: 781- 795.
3. Moore MJ. Clinical pharmacokinetics of Cyclophosphamide. Clin Pharmacokinet 1991;20: 194-208.
4. Loadman PM, Bibby MC. Pharmacokinetic drug interactions with anti-cancer drugs. Clin. Pharmacokinet. 1994;26: 486-500.
5. Kehrer JP, Biswal SS. The molecular effect of acrolein. Toxicol Sci 2000;57: 6-15. 6. Ferguson LR. Mutation Res 2001; 475: 89-111.
6. De Salvia R, Fiore M, et al. Inhibitory action of melatonin on H2 O2 and Cyclophosphamide-induced DNA damage. Mutagenesis 1999; 14: 107-112.
7. Mazur L, Augustynek A, Bochenek M. Flow cytometric estimation of the plasmamembrane diversity of bone marrowcells in mice treated withWR-2721 and Cyclophosphamide. Toxicology 2002; 171: 63-72.
8. Kern JC, Kehrer JP. Acrolein-induced cell death: a caspaseinfluenced decision between apoptosis and oncosis/necrosis, Chem Biol Interact 2002:139: 79-95.
9. Arumugam N, Sivakumar V, et al. Effects of acrolein on rat liver antioxidant defense system. Indian J Exp Biol 1997; 35:s 1373-1374.
10. Mythili Y, Sudharsan PT, Selvakumar E, Varalakshmi P. Protective effect of dl lipoic acid on cyclophosphamide induced oxidative cardiac injury, Chem Biol Interact 2004; 151: 13-19.
11. Kawanishi M, Matsuda T, et al. Molecular analysis of mutations induced by acrolein in human fibroblast cells using supf shuttle vector plasmids. Mut Res Gen Toxicol Environ Mutagen 1998; 417: 65-73.
12. Anderson D, Bishop JB, Garner RC, Ostrosky-Wegman P, et al. Cyclophosphamide: review of its mutagenicity for an assessment of potential germ cell risks. Mutation Res 1995; 330: 115-182.
13. Qiu J, Hales BF, Robaire B. Effects of chronic low dose Cyclophosphamide exposure on the nuclei of rat spermatozoa. Biol Reprod 1995; 52: 33-40.
14. Eastman A, Barry MA. The origins of DNA breaks: a consequence of DNA damage, DNA repair or apoptosis. Cancer Invest 1992;10: 229-240.
15. Abdel-Wahhab MA, Aly SE. Antioxidant property of Nigella sativa (Black cumin) and Syzygium aromaticum (Clove) in rats during aflatoxicosis. J Appl Toxicol 2005; 25: 218-223.
16. Abdel-Wahhab MA, Aly SE. Antioxidants and radical scavenging properties of vegetable extracts in rats fed aflatoxin contaminated diet. J Agric Food Chem 2003; 51: 2409-2414.
17. Kada T, Kaneko K, Matsuzaki S, et al. Detection and chemical identification of natural bioantimutagen: A case of green tea factor. Mutation Res 1985; 150: 127-132.
18. Kada T, Morita K, Inoue T. Antimutagenic action of vegetable factor(s) on the mutagenic principle of tryptophan pyrolysate. Mutation Res 1978; 53: 351-353.
19. Wall ME, Wani MC, Manikumar G, Abraham P, et al. Plant antimutagenic agents 2. Flavonoids. Journal of Natural Products 1988b; 51: 1084-1091.
20. Wall ME, Wani MC, Hughes TJ, Taylor H. Plant antimutagenic agents 1. General bioassay and isolation procedures. Journal of Natural Products 1988a; 51: 866-873.
21. Wall ME, Wani MC, Manikumar G. Plant antimutagens.6. Intricatin and intricatinol, new anti- mutagenic homoisoflavonoids from Hofmanosseggia intricata. Journal of Natural Products 1989; 52: 774-778.
22. Wattenberg LW, Loub WD, Lam LK, Speier JL. Dietary constituents altering the response to chemical carcinogens. Federation Proceedings 1976; 35: 1327-1331.
23. Flora SD. Mechanisms of inhibitors of mutagenesis and carcinogenesis, Mutatation Res 1998; 402: 151-158.
24. Flora S D, Izzotti A, Agostini FD, Balansky RM, et al. Multiple points of intervention in the prevention of cancer and other mutation-related diseases. Mutation Res 2001; 480: 9- 2.
25. Weisburger JH. Antimutagenesis and anticarcinogenesis from the past to future, Mutatation Res 2001; 481: 23-35.
26. Osawa T, Katsuzaki H, Kumon H, Kawakishi S, et al. Protective role of phenolic antioxidants in plants against oxidative damage. In: Frontiers of active oxygen species in biology and medicine (Asada K., and Yoshikawa T. eds.) Excerpta Medica, The Netherlands 1994; 333-336.
27. Rice-Evans C, Halliwell B, Lunt GG. Free radicals and oxidative stress: Environment, Drugs and Food additives, 2nd ed. London: Portland press 1995.
28. Noda Y, Anza K, Mori, A, et al. Hydroxyl and superoxide anion radical scavenging activities of natural source antioxidants using the computerized JES-FR30 ESR spectromoter system. Bioch Mol Biol Internat 1997; 42:35-44.
29. Hordegen P, Cabaret J, Hertzberg H, et al. In vitro screening of six anthelmintic plant products against larval Haemonchus contortus with a modi{Thorn} ed methyl-thiazolyltetrazolium reduction assay. J Ethnopharmacol 2006;108:85-9.
30. Pandey VN. Pharmacological Investigation of Certain Medicinal Plants and Compound Formulations Used in Ayurveda and Siddha. Central Council for Research in Ayurveda and Siddha, Yugantar Press, New Delhi, India, 1st edition 1996; pp. 370-376.
31. Vaidya AMR. "Sthaulya Cikitsa (treatment of obesity)," in A Compendium of Ayurvedic Medicine, Principles and Practice, Sri Satyaguru Publication. A division of Indian Book Centre, New Delhi, India. 1999; pp. 335-339
32. Rani P, Khullar N. Antimicrobial evaluation of some medicinal plants for their antienteric potential against multi-drug resistant Salmonella typhi. Phytotherapy Res 2004; 18: 670- 673.
33. Gupta S, Sanyal SN, Kanwar U. Antispermatogenic effect of embelin, a plant benzoquinone, on male albino rats in vivo and in vitro. Contraception 1989; 39: 307-320.
34. Tabassum N, Agarwal SS. Hepatoprotective activity of Embelia ribes against paracetamol induced acute hepatocellular damage in mice. Experimental medicine 2003; 10: 43-44.
35. Tripathi SN. Screening of hypoglycemic action in certain indigenous drugs. Journal of Research in Indian Medicine, Yoga and Homeopathy 1979; 14: 159-169.
36. Kirthikar KR, Basu BD. Indian Medicinal Plants. Lalit Mohan Basu, Vol. 2. Allahabad, India, 1987. p. 1479.
37. Bhandari U, Ansari MN, Islam F. Cardioprotective effect of aqueous extract of Embelia ribes Burm fruits against isoproterenol- induced myocardial infarction in albino rats. Indian J Exp Biol 2008; 46:35-40.
38. Bhandari U, Jain N, Pillai KK. Further studies on antioxidant potential and protection of pancreatic β-cells by Embelia ribes in Experimental diabetes. Exp Diabetes Research 2007;1-6.
39. Singleton LV, Orthofer R, Lamuela-Raventos RML. Analysis of Total Phenols and Other Oxidation Substrates and Antioxidants by Means of Folin-Ciocalteu Reagent Method. Enzymology 1999; 299: 152-178.
40. Woisky R, Salatino A. Analysis of propolis: some parameters and procedures for chemical quality control, J Apic Res 1998; 37: 99-105.
41. Preston RJ, Dean BJ, Galloway S. et al. Mammalian in vivo cytogenetics assays: analysis of chromosome aberrations in bone marrow cells. Mutation Res 1987;189: 157-165.
42. W.H.O. (World Health Organization) Guide to short term tests for detecting mutagens & arcinogens chemicals Environmental Health Criteria, 51, WHO, Geneva 1976; 100-114.
43. Tice RR, Luke CA, Shelby MD. Methyl isocynate: an evaluation of in vivo cytogenetic activity. Environmental mutagenesis 1987; 9: 37-58.
44. Schmid W. The micronucleus test. Mutation Res 1975; 35: 9-15.
45. Cole R, Cole C. Transplacental effects of chemical mutagens detected by the micronucleus test. Nature 1979; 277: 317-318.
46. Bruce WR, Furrer R, Wyrobek AJ. Abnormalities in the shape of murine sperm after cute testicular X-irradiation. Mutatation Res 1974; 23: 381-386.
47. Lowery OH, Rosebrough JN, Farr AL, Randall RJ. Protein measurement with the Folinreagent. J Bio Chem 1951; 193: 265-275.
48. Ohkawa I, Ohisi N, Yagi K. Assay for lipid peroxides in animal tissue by thiobarbituric acid reaction. Anal Biochem 1979; 95: 351-358.
49. Teitz F. Enzymatic method of quantitative determination of nanogram amounts of total and oxidized glutathione. Analytical Biochemistry 1967; 27: 502-550.
50. Misra HP, Fridovich I. The role of superoxide anion in the antioxidation of epinephrine and a simple assay for Superoxide dismutase. J Biol Chem 1972; 247: 31-70.
51. Aebi HE. Catalase methods of enzymatic analysis. Vrerleg Chemie Acad Press Inc. 3,1974; 273-286.
52. Jackson MA, Stack HF, Waters MD. Genetic activity profiles of anticancer drugs, Mutation Res 1996; 355:171-208.
53. Krishna GJ, Petrere J, Anderson J. Theiss, Use of cyclophosphamide as a positive control in dominant lethal and mammalian assays, Mutatation Res 1995; 355: 331-337.
54. Iain BL, Timothy MS, Sherri EB, George RD. Detailed review of transgenic rodent mutation assays. Mutation Res 2005; 590: 1-280.
55. Salamone MF, Heddle JA. New York: Plenium Press, 1983:111-149.
56. Rabello-Gay MN. Teste do Micronúcleo em Medula Óssea. In: Mutagênese, teratogênese e carcinogênese: métodos e critérios de avaliação, Ed. SBG, Ribeirão Preto, 1991; 246.
57. Au WW, Hsu TC. The genotoxic effects of adriamycin in somatic and germinal cells of mouse. Mutatation Res 1980; 79: 351-361.
58. Wyrobek AJ, Gordon LA, Burkhart JG, Francis MW. et al. An evaluation of human sperm as indicators of chemically induced alterations of spermatogenic function. Mutatation Res 1983; 115, 73-148.
59. Patel JM, Block ER. Cyclophosphamide-induced depression of the antioxidant defense mechanisms of the lung. Exp. Lung Res 1985; 8:153-165.
60. Lear L, Nation RL, Stupans I. Effects of cyclophosphamide and adriamycin on rat hepatic microsomal glucuronidation and lipid peroxidation. Biochem Pharmacol 1992; 44: 747- 753.
61. Venkatesan N, Chandrakasan G. Modulation of cyclophosphamide-induced early lung injury by curcumin, an anti-inflammatory antioxidant. Mol Cell Biochem 1995; 142: 79-87.
62. Mathew S, Kuttan G. Antioxidant activity of Tinospora cordifolia and its usefulness in the amelioration of cyclophosphamide induced toxicity, J Exp Clin Cancer Res 1997; 16: 407-411.
63. Premkumar K, Pachiappan A, Abraham SK, et al. Effect of Spirulina fusiformis on cyclophosphamide and mitomycin-C induced genotoxicity and oxidative stress in mice. Fitoterapia 2001;72: 906-911.
64. Sladek NE. Metabolism of Cyclophosphamide by rat hepatic microsomes. Cancer Res 1971; 31: 901-908.
65. Sladek NE. Metabolism of oxazaphosphorines. Pharmacol Ther 1988; 37: 301-355.
66. Dumontet C, Drai J, Thieblemont C, et al. The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br J Haematol 2001; 112: 405-409.
67. Lopes, G.K., Schulman, H.M., Hermes-Lima, M.,1999. Biochim. Biophys. Acta 1472: 142-152.
68. Stoner GD, Mukhtar H J. Polyphenols as cancer chemopreventive agents. Cell Biochem (Suppl). 1995; 22: 169-180.
69. Stich F, Rosin MP. Naturally occurring phenolics as antimutagenic and carcinogenic agents. In: M. Friedman (Ed.), Nutritional and toxicological aspects of food safty, Pletinum, New York, 1984, pp. 1-29.
70. Ho CT. Phenolic compounds in food: an overview. In: M. T. Huang, C.T. Ho. And C.Y. Lee (eds.), Phenolic compounds in food and their effects on health II. Antioxidants and cancer prevention, American chemical Society, Washington 1992; 2-7.
71. Kuo M, Lee K, Lin J, Genotoxicities of nitropyrenes and their modulation by epigenin, tannic acid, Ellagic acid and indole-3-carbinol in the Salmonella and CHO systems, Mutation Res 1995; 87-95.
72. Stavric B. Antimutagens and anticarcinogens. Food Chem Toxicol 1994; 32: 79-90.
73. Chitra M, Sukumar E, Devi CSS. [3H]-Thymidine uptake and lipid peroxidation by tumor cells on embelin treatment: An in vitro study Oncology (Basal) 1995; 52: 66-8.
74. Joshi R, Kamath J., Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: Biochemical and pulse radiolytic studies. Chemico-Biological Interactions 2007;167: 125-134.
75. Guerra MC, Galvano F, Bonsi L, et al. Cyanidin-3-O-beta-glucopyranoside, a natural free-radical scavenger against aflatoxin B1- and ochratoxin A-induced cell damage in a human hepatoma cell line (Hep G2) and a human colonic adenocarcinoma cell line (CaCo-2). British J Nutr 2005; 94: 211-220.
76. Galvano F, Piva F, Riteni A, Galvano G. Dietery strategies to counteract the effects of mycotoxins: a review. J Food Prot 2001; 64: 120-131.